✦ LIBER ✦

Vanganciclovir prophylaxis for the prevention of cytomegalovirus reactivation and disease in allogeneic stem cell transplantation recipients

✍ Scribed by M. Magalhaes-Silverman; T. Carter; R. Hohl; H. Shamsuddin; R. Gingrich

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preemptive Therapy for Cytomegalovirus D

✍ F. de la Cruz-Vicente; P. Cerezuela Martinez; E. Gil-Espárraga; C. Martin Aguile 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 92 KB

252Valacyclovir compared to acyclovir fo

✍ A.S. Artz; N. Dieterle; J. Gelms; S. Parsad; R. Larson; W. Stock; C. Daugherty; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Maribavir prophylaxis for prevention of

✍ Francisco M Marty; Per Ljungman; Genovefa A Papanicolaou; Drew J Winston; Roy F 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 259 KB

Valganciclovir for the prophylaxis of ea

✍ C. Bachier; P. Shaughnessy; D. Wall; M. Grimley; G. Carrum; C. Freytes; N. Calla 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 68 KB

HB Vaccination in the Prevention of Vira

✍ Masahiro Onozawa; Satoshi Hashino; Stephanie Darmanin; Kohei Okada; Rena Morita; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 186 KB

A randomized trial of preemptive therapy

✍ Seung Tae Kim; Mark H. Lee; Sung Yong Kim; Seok Jin Kim; Dong Hwan Kim; Jun Ho J 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 207 KB